Trial Profile
Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Hypotrichosis
- Focus Registrational; Therapeutic Use
- Sponsors Allergan
- 22 May 2014 New trial record
- 09 Jun 2011
- 23 Jun 2010